Wellcome Trust Sanger Institute

The Wellcome Trust Sanger Institute was formed in 1992 for the purposes of funding biomedical research. Specifically genome sequencing efforts. It is the largest charity in the U.K., and receives a majority of its funds from the Wellcome Trust. The Institute is responsible for the completion of the sequencing of approximately 1/3 of the human genome and model genomes of the mouse and zebrafish and more than 90 pathogen genomes. Today, the Wellcome Trust Sanger Institute has been able to attract top scientists and has more than 30 Senior Researchers on staff. The Institute is located in Hinxton, Cambridge, U.K., and spends approximately 650 British Pounds annually to support relevant research by preeminent scientists and labs around the globe. The Institute supports work at the University of Nottingham, MIT, University of Toronto, University of Gothenburg, University of Manchester and other institutions of higher learning research labs.

Address
Hinxton, Cambs, CB10 1SA, UK
E-mail
press.officer@sanger.ac.uk
Some content from Wikipedia, licensed under CC BY-SA

Using healthy skin to identify cancer's origins

Normal skin contains an unexpectedly high number of cancer-associated mutations, according to a study published in Science. The findings illuminate the first steps cells take towards becoming a cancer and demonstrate the ...

May 21, 2015
popularity42 comments 0

Patient cancer cells help to test treatments

A study, published today in Cell, demonstrates the power of organoids to capture, in three dimensions, the multiple mutations that occur in tumours. Organoids, small clusters of cells that accurately mimic the behaviour of ...

May 07, 2015
popularity20 comments 0

Drug target for asthma discovered

The over-active immune cells responsible for asthma depend on the gene BCL11B to develop into mature cells, according to a study published in the Journal of Experimental Medicine. The identification of this gene's role could ...

May 13, 2015
popularity48 comments 0

Novel breast cancer gene found

A new study identifies a gene that is especially active in aggressive subtypes of breast cancer. The research suggests that an overactive BCL11A gene drives triple-negative breast cancer development and progression.

Jan 09, 2015
popularity757 comments 0